Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05930483 · ClinicalTrials.gov registry record · NA

Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

A NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by Fred Hutchinson Cancer Center.

Recruiting
Registry status
NA
Development phase
640
Enrollment target
1
Study location

NCT05930483 is a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 640 participants, above the 297-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05930483, a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.

RECRUITING
Registry status
NA
Development phase
640 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates remotely delivered, community-aligned weight loss interventions in Latina breast cancer survivors. Breast cancer is the second leading cause of cancer death among women in the US. There are population differences in breast cancer mortality, based on specific risk factors, including obesity. Cancer is the leading cause of death among Latinos, and among Latinas, breast cancer is the leading cause of cancer death. An estimated 80% of Latinas in the United States have overweight/obesity, which is associated with poorer breast cancer outcomes. However, few, if any, effective interventions exist to promote and maintain weight loss in Latina breast cancer survivors. The development of an adaptive program that provides survivors with the support they need, as opposed to what is typically available, to improve breast cancer survivorship.

Interventions

  • BEHAVIORAL Health Coaching
  • BEHAVIORAL ¡Vida! program
  • BEHAVIORAL ¡Vida! Plus [¡Vida! + Experiential Learning (EL)]
  • BEHAVIORAL Mailed Toolkits

Study Locations (1)

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 640 participants
Start Date 2025-04-08
Est. Completion 2028-03-01
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT05930483

The ClinicalTrials.gov registry entry for NCT05930483 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 640 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 297-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (115% higher). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anatomic Stage III Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Health Coaching is the first listed.

NCT05930483 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05930483 about?

NCT05930483 is a clinical study titled "Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial". This clinical trial evaluates remotely delivered, community-aligned weight loss interventions in Latina breast cancer survivors. Breast cancer is the second leading cause of cancer death among women in the US. There are population differences in breast cancer mortality, based on specific risk factor...

What is the current status of trial NCT05930483?

This trial is currently recruiting. It is a NA study. The enrollment target is 640 participants. The study started on 2025-04-08. Estimated completion is 2028-03-01.

What conditions does trial NCT05930483 study?

This clinical trial studies the following conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8.

What interventions are being tested in trial NCT05930483?

The interventions under investigation include: Health Coaching (BEHAVIORAL), ¡Vida! program (BEHAVIORAL), ¡Vida! Plus [¡Vida! + Experiential Learning (EL)] (BEHAVIORAL), Mailed Toolkits (BEHAVIORAL).

Who is sponsoring clinical trial NCT05930483?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05930483 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anatomic Stage III Breast Cancer AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.